文献速递湿疹皮炎与荨麻疹

2012至2017年美国联邦医疗保险受益人斑贴试验的使用、费用与提供者趋势

Utilization, cost, and provider trends in patch testing among Medicare beneficiaries in the United States from 2012 to 2017.
PubMed 文献 · J Am Acad Dermatol · 2020-05-05

本研究回顾性分析2012至2017年联邦医疗保险提供者使用与支付数据,评估斑贴试验的地理可及性及费用、使用和提供者专科趋势。2017年仅20.3%都市县和1.1%非都市县可提供斑贴试验;都市区皮肤科医生测试受益人年均增长1.84%,过敏科医生增长20.31%。大多数人均使用80片以上斑贴的提供者为皮肤科医生(76.3%)。

要点

  • 2017年斑贴试验仅覆盖20.3%都市县和1.1%非都市县,地理可及性不均。
  • 2012至2017年都市区过敏科医生测试受益人年均增长20.31%,远高于皮肤科医生的1.84%。
  • 人均使用80片以上斑贴的提供者中76.3%为皮肤科医生。

核心结论

  • 2012至2017年斑贴试验使用的增长主要集中在都市区,过敏科医生增长显著,但多数全面斑贴试验由皮肤科医生完成。

研究设计与样本

  • 回顾性队列研究,分析2012至2017年联邦医疗保险提供者使用与支付数据。

主要发现

  • 截至2017年,斑贴试验在20.3%的都市县和1.1%的非都市县可及。
  • 2012至2017年都市区皮肤科医生测试的受益人数年均增长1.84%,过敏科医生年均增长20.31%。
  • 平均每位受益人使用80片或以上斑贴的提供者中,76.3%为皮肤科医生。

临床怎么用

  • 皮肤科医生应关注斑贴试验在非都市区可及性不足的现状,并了解过敏科医生在都市区使用增长的趋势。

局限性

  • 分析仅限于联邦医疗保险Part B索赔数据,无法获取商业保险人群信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patch testing is the best diagnostic test for allergic contact dermatitis. However, there is presently a lack of data on the test's geographic availability and the characteristics of the providers offering this test across the United States. OBJECTIVE: To evaluate the geographic variation in the availability of patch testing for the Medicare population and to characterize the temporal trends of patch testing cost, use, and provider specialty from 2012 to 2017. METHODS: Retrospective cohort study of the Medicare Provider Utilization and Payment Data from 2012 to 2017. RESULTS: As of 2017, patch testing was available in 20.3% of metropolitan counties and in 1.1% of nonmetropolitan counties. From 2012 to 2017 in metropolitan regions, the number of beneficiaries tested by dermatologists grew by an average annual growth rate of 1.84%, whereas those tested by allergists grew by an average annual growth rate of 20.31%. Most providers that averaged use of 80 or more patches per beneficiary were dermatologists (76.3%). LIMITATIONS: Analysis was restricted to Medicare Part B claims; data were unavailable on individuals with commercial insurance. CONCLUSIONS: Most of the increase in patch testing utilization from 2012 to 2017 has been in metropolitan regions. Although growth was especially prominent among allergists in metropolitan counties, the majority of providers performing comprehensive patch testing were dermatologists.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Cheraghlou S, Watsky KL, Cohen JM, et al. Utilization, cost, and provider trends in patch testing among Medicare beneficiaries in the United States from 2012 to 2017. J Am Acad Dermatol. 2020. PMID: 32387633. doi:10.1016/j.jaad.2020.04.163

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。